1. Spinas E, Kritas SK, Saggini A, et al. Role of mast cells in atherosclerosis: a classical inflammatory disease. Int J Immunopathol Pharmacol. 2014;27:517-21.
2. Bot I, Shi GP, Kovanen PT. Mast cells as effectors in atherosclerosis. Arterioscler Thromb Vasc Biol. 2015;35:265-71.
3. Heikkilä HM, Trosien J, Metso J, et al. Mast cells promote atherosclerosis by inducing both an atherogenic lipid profile and vascular inflammation. J Cell Biochem. 2010 ;109:615-23.
4. Wang J, Sjöberg S, Tia V, et al. Pharmaceutical stabilization of mast cells attenuates experimental atherogenesis in low-density lipoprotein receptor-deficient mice. Atherosclerosis. 2013;229:304-9.
5. Lappalainen J, Lindstedt KA, Oksjoki R, Kovanen PT. OxLDL-IgG immune complexes induce expression and secretion of proatherogenic cytokines by cultured human mast cells. Atherosclerosis. 2011;214:357-63.
6. Matsuura E, Atzeni F, Sarzi-Puttini P, et al. Is atherosclerosis an autoimmune disease? BMC Med. 2014 Mar 18;12:47.
7. Bouzid MA, Filaire E, McCall A, Fabre C. Radical Oxygen Species, Exercise and Aging: An Update. Sports Med. 2015;45:1245-61.
8. Siri-Tarino PW, Sun Q, Hu FB, Krauss RM. Meta-analysis of prospective cohort studies evaluating the association of saturated fat with cardiovascular disease.Am J Clin Nutr. 2010;91:535-46.
9. de Lorgeril M, Salen P New insights into the health effects of dietary saturated and omega-6 and omega-3 polyunsaturated fatty acids. BMC Med. 2012;10:50.
10. Delgado-Lista J, Perez-Martinez P, Lopez-Miranda J, et al. Long chain omega-3 fatty acids and cardiovascular disease: a systematic review. Br J Nutr. 2012 ;107 Suppl 2:S201-13.
11. Martínez-González MA, Salas-Salvadó J, Estruch R, et al. Benefits of the Mediterranean Diet: Insights From the PREDIMED Study. Prog Cardiovasc Dis. 2015;58:50-60.
12. Jones JL, Comperatore M, Barona J, et al. A Mediterranean-style, low-glycemic-load diet decreases atherogenic lipoproteins and reduces lipoprotein (a) and oxidized low-density lipoprotein in women with metabolic syndrome. Metabolism. 2012;61:366-72.
13. Awad AB, Chattopadhyay JP. Alteration of rat heart sarcolemma lipid composition by dietary elaidic acid.J Nutr. 1983;113:913-20.
14. Siguel EN, Lerman RH. Trans-fatty acid patterns in patients with angiographically documented coronary artery disease. Am J Cardiol. 1993;71:916-20.
15. Willett WC, Stampfer MJ, Manson JE, etal. Intake of trans fatty acids and risk of coronary heart disease among women.Lancet. 1993;341(8845):581-5.
16. R. Micha, D. Mozaffarian. Trans Fatty Acids: Effects on Cardiometabolic Health and Implications for Policy.Prostaglandins Leukot Essent Fatty Acids. 2008; 79: 147–152.
17. Morris MC, Evans DA, Bienias JL, et al. Dietary fats and the risk of incident Alzheimer disease.Arch Neurol. 2003;60:194-200.
18. Gebauer SK, Chardigny JM, Jakobsen MU, et al. Effects of ruminant trans fatty acids on cardiovascular disease and cancer: a comprehensive review of epidemiological, clinical, and mechanistic studies. Adv Nutr. 2011;2:332-54.
19. Hu J, La Vecchia C, de Groh M, et al. Dietary transfatty acids and cancer risk. Eur J Cancer Prev. 2011 ;20:530-8.
20. 109-Sullivan S. Implications of diet on nonalcoholic fatty liver disease. Curr Opin Gastroenterol. 2010 ;26:160-4.
21. Thompson AK, Minihane AM, Williams CM. Trans fatty acids and weight gain. Int J Obes (Lond). 2011;35:315-24.
22. Frohlich J, Al-Sarraf A. Cardiovascular risk and atherosclerosis prevention. Cardiovasc Pathol. 2013;22:16-8.
23. Park JH, Park H, Lim ST, Park JK. Effects of a 12-week healthy-life exercise program on oxidized low-density lipoproteincholesterol and carotid intima-media thickness in obese elderly women. J Phys Ther Sci. 2015;27:1435-9.
24. Ortega RM, Requejo AM, Andrés P, Gaspar MJ, Ortega A.Milk and dairy products in the prevention and control of cardiovascular diseases. Nutr Hosp. 1993 ;8:395-404.
25. Pfeuffer M, Schrezenmeir J. Bioactive substances in milk with properties decreasing risk of cardiovascular diseases. Br J Nutr. 2000 ;84 Suppl 1:S155-9.
26. Hidaka H, Takiwaki M, Yamashita M,et al. Consumption of nonfat milk results in a less atherogenic lipoprotein profile: a pilot study. Ann Nutr Metab. 2012;61:111-6.
27. Hu FB, Stampfer MJ, Rimm EB, et al. A prospective study of egg consumption and risk of cardiovascular disease in men and women. JAMA. 1999 ;281:1387-94.
28.Scrafford CG, Tran NL, Barraj LM, Mink PJ. Egg consumption and CHD and stroke mortality: a prospective study of US adults. Public Health Nutr. 2011;14:261-70.
29.Kritchevsky SB, Kritchevsky D. Egg consumption and coronary heart disease: an epidemiologic overview. J Am Coll Nutr. 2000;19(5 Suppl):549S-555S.
30. Rong Y, Chen L, Zhu T, et al. Egg consumption and risk of coronary heart disease and stroke: dose-response meta-analysis of prospective cohort studies. BMJ. 2013 7;346:e8539.
31. Robbins JM, Petrone AB, Ellison RC, et al. Association of egg consumption and calcified atherosclerotic plaque in the coronary arteries: the NHLBI Family Heart Study. ESPEN J. 2014 ;9:e131-e135.
32. Choi Y, Chang Y, Lee JE, et al. Egg consumption and coronary artery calcification in asymptomatic men and women. Atherosclerosis. 2015;241:305-12.
33. Scott BB, Swinburne ML, McGuffin P, Losowsky MS. Dietary antibodies and myocardial infarction. Lancet. 1976;2(7977):125-6.
34. Gibney MJ, Gallagher PJ, Sharratt GP,et al. Antibodies to heated milk protein in coronary heart disease. Atherosclerosis. 1980 ;37:151-5.
35. Muscari A, Volta U, Bonazzi C, et al. Association of serum IgA antibodies to milk antigens with severe atherosclerosis. Atherosclerosis . 1989;77:251-6.
36. Wilders-Truschnig M, Mangge H, Lieners C, et al. IgG antibodies against food antigens are correlated with inflammation and intima media thickness in obese juveniles. Exp Clin Endocrinol Diabetes. 2008;116:241-5.
37. Cinemre H, Bilir C, Gokosmanoglu F, Kadakal F. Anti-Saccharomyces cerevisiae antibodies in acute myocardial infarction. J Investig Med. 2007;55:444-9.
38. West J, Logan RF, Card TR, Smith C, Hubbard R. Risk of vascular disease in adults with diagnosed coeliac disease: a population-based study. Aliment Pharmacol Ther. 2004;20:73-9.
39. Ludvigsson JF, James S, Askling J, Stenestrand U, Ingelsson E. Nationwide cohort study of risk of ischemic heart disease in patients with celiac disease. Circulation. 2011;123:483-90.
40. De Marchi S, Chiarioni G, Prior M, Arosio E.Young adults with coeliac disease may be at increased risk of early atherosclerosis. Aliment Pharmacol Ther. 2013 ;38:162-9.
41. Emilsson L, James S, Ludvigsson JF. Ischemic heart disease in first-degree relatives to celiac patients. Eur J Clin Invest. 2014 Jan 29.
42. Ludvigsson JF, West J, Card T, Appelros P. Risk of stroke in 28,000 patients with celiac disease: a nationwide cohort study in Sweden. J Stroke Cerebrovasc Dis. 2012;21:860-7.
43. Odia OJ, Ofori S, Maduka O. Palm oil and the heart: A review. World J Cardiol. 2015 ;7(3):144-9.
44. Lovejoy JC, Bray GA, Lefevre M, Consumption of a controlled low-fat diet containing olestra for 9 months improves health risk factors in conjunction with weight loss in obese men: the Ole’ Study. Int J Obes Relat Metab Disord. 2003;27:1242-9.
45. Fouad FM, Mamer O, Sauriol F et al. Cardiac heart disease in the era of sucrose polyester, Helicobacter pylori and Chlamydia pneumoniae. Med Hypotheses. 2004;62:257-67.
46. Dearfield KL, Abernathy CO, Ottley MS, et al. Acrylamide: its metabolism, developmental and reproductive effects, genotoxicity, and carcinogenicity. Mutat Res. 1988;195:45-77.
47. Rice JM. The carcinogenicity of acrylamide. Mutat Res. 2005;580:3-20.
48. Mustafa HN. Effect of acrylamide on testis of albino rats. Ultrastructure and DNA cytometry study. Saudi Med J. 2012;33:722-31.
49. Stott-Miller M, Neuhouser ML, Stanford JL. Consumption of deep-fried foods and risk of prostate cancer. Prostate. 2013 Jan 17.
50. Kounis NG. Coronary hypersensitivity disorder: the Kounis syndrome. Clin Ther. 2013;35:563-71.
51. Nikolaidis LA, Kounis NG, Gradman AH. Allergic angina and allergic myocardial infarction: a new twist on an old syndrome. Can J Cardiol. 2002;18:508-11.
52. Emilsson L, Andersson B, Elfström P, Green PH, Ludvigsson JF. Risk of idiopathic dilated cardiomyopathy in 29 000 patients with celiac disease. J Am Heart Assoc. 2012;1:e001594.
53. Menezes TM, Motta ME. Celiac disease prevalence in children and adolescents with myocarditis and dilated cardiomiopathy. J Pediatr (Rio J). 2012;88:439-4.
54.Vizzardi E, Lanzarotto F, Carabellese N,et al. Lack of association of coeliac disease with idiopathic and ischaemic dilatedcardiomyopathies. Scand J Clin Lab Invest. 2008;68:692-5.
55. De Bem RS, Da Ro Sa Utiyama SR, Nisihara RM,et al. Celiac disease prevalence in Brazilian dilated cardiomyopathy patients. Dig Dis Sci. 2006;51:1016-9.
56. Chicco D, Taddio A, Sinagra G,et al. Speeding up coeliac disease diagnosis in cardiological settings. Arch Med Sci. 2010;6:728-32.
57.Yacoub M, Mahjoub H, Abroug S,et al. Idiopathic pulmonary hemosiderosis, celiac disease and cardiomyopathy. Arch Pediatr. 1994;1:587-90.
58. Ouali S, Chabrak S, Larbi N, Kafsi N. Dilated cardiomyopathy and atrio-ventricular block in coeliac disease. Two case reports. Arch Mal Coeur Vaiss. 2006;99:1252-5.
59.Mazurkiewicz L, Bilińska ZT, Witkowski A,et al. Myocardial microabscesses detected by endomyocardial biopsy in a patient with dilatedcardiomyopathy and celiac disease: a case report. Kardiol Pol. 2006;64:733-6.
60. Winter Del R JL, Gabrielli N L, Greig D, et al. Dilated cardiomyopathy in celiac disease: report of one case. Rev Med Chil. 2009;137:1469-73.
61. Curione M, Barbato M, Viola F,et al. Idiopathic dilated cardiomyopathy associated with coeliac disease: the effect of a gluten-free diet on cardiac performance. Dig Liver Dis. 2002 ;34:866-9.
62. McGrath S, Thomas A, Gorard DA .Cardiomyopathy responsive to gluten withdrawal in a patient with coeliac disease . BMJ Case Rep. 2016;2016.
63. Agüero J, Navarro J, Medina MC, et al. Clinical variables associated with the presence of inflammatory infiltrates in patients with dilated cardiomyopathy undergoing heart transplantation. Transplant Proc. 2008;40:3017-9.
64. Gavrisheva NA, Tkachenko SB. [Mast cells in normal and diseased heart]. Kardiologiia. 2003;43:59-65.
65. Frustaci A, Cuoco L, Chimenti C,et al. Celiac disease associated with autoimmune myocarditis. Circulation. 2002 ;105:2611-8.
66. Mina Y, Rinkevich-Shop S, Konen E, et al. Mast cell inhibition attenuates myocardial damage, adverse remodeling, and dysfunction during fulminant myocarditis in the rat.J Cardiovasc Pharmacol Ther. 2013 Mar;18(2):152-61. Epub 2012 Nov 19.
67. Terai M, Yasukawa K, Honda T, Jibiki T, Hirano K, Sato J, Ishiwada N, Seguchi M, Ueda S, Kohno Y.Peripheral blood eosinophilia and eosinophil accumulation in coronary microvessels in acuteKawasaki disease. Pediatr Infect Dis J. 2002 Aug;21(8):777-81.
68. Stagi S, Simonini G, Ricci L, de Martino M, Falcini F. Coeliac disease in patients with Kawasaki disease. Is there a link? Rheumatology (Oxford). 2006 ;45:847-50.
69. Di Cara G, Berioli MG, Biscarini A, et al. Echocardiographic alterations in a child with cow’s milk allergy: a case report. J Med Case Rep. 2012 ;6(1):299.
70. Berthoux E, Fabien N, Chayvialle JA, Ninet J, Durieu I. Adult celiac disease with thrombosis: a case series of seven patients. Role of thrombophilic factors. Rev Med Interne. 2011;32:600-4.
71. Shamir R, Shoenfeld Y, Blank M,et al. The prevalence of coeliac disease antibodies in patients with the antiphospholipid syndrome. Lupus. 2003;12:394-9.
72. Armentia A, Barber D, Lombardero M, Martín Santos JM, Martin Gil FJ, Arranz Peña ML, Callejo A, Salcedo G, Sánchez-Monge R. Anaphylaxis associated with antiphospholipid syndrome. Ann Allergy Asthma Immunol. 2001 Jul;87(1):54-9.
73. Armentia A, Mazón A, Pineda F, Palacios R, Crespo J, Inglada L, Martín-Santos JM, García-Frade J, Martín-Armentia B. Food anaphylaxis in antiphospholipid syndrome and thrombosis. Allergol Immunopathol (Madr). 2011 Jul-Aug;39(4):212-21. Epub 2011 Jan 7.
74. Casella G, Bassotti G, Villanacci V,et al. Is hyperhomocysteinemia relevant in patients with celiac disease?World J Gastroenterol. 2011;17:2941-4.
75. Dickey W, Ward M, Whittle CR,et al. Homocysteine and related B-vitamin status in coeliac disease: Effects of gluten exclusion and histological recovery. Scand J Gastroenterol. 2008;43:682-8.
76.Levick SP, Meléndez GC, Plante E,et al. Cardiac mast cells: the centrepiece in adverse myocardial remodelling.
Cardiovasc Res. 2011; 89:12-9.
77.Janicki JS, Brower GL, Levick SP. The emerging prominence of the cardiac mast cell as a potent mediator of adverse myocardial remodeling.
Methods Mol Biol. 2015;1220:121-39.
